KPIs & Operating Metrics(New)
Breakdown Of AssetsCost Of RevenueDiaggregated Revenue AnnualDiaggregated Revenue Mix Annual %Disaggregated RevenueDisaggregated Revenue Mix %Employee StatisticsIncome Before Provisions For Income TaxesNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Opex As A % Of RevenueOPEX BreakdownProfitability AnnualProperty And Equipment, NetRevenueRevenue AnnualRevenue From PayorsRevenue From Payors AnnualRevenue Mix From Payors %Revenue Mix From Payors Annual %Test Reports DeliveredTest Reports Delivered BreakdownTest Reports Delivered Total
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Castle Biosciences (CSTL) Revenue (2018 - 2025)

Castle Biosciences (CSTL) has disclosed Revenue for 8 consecutive years, with $87.0 million as the latest value for Q4 2025.

  • Quarterly Revenue rose 0.81% to $87.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $344.2 million through Dec 2025, up 3.66% year-over-year, with the annual reading at $344.2 million for FY2025, 3.66% up from the prior year.
  • Revenue hit $87.0 million in Q4 2025 for Castle Biosciences, up from $83.0 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $88.0 million in Q1 2025 to a low of $22.8 million in Q2 2021.
  • Historically, Revenue has averaged $56.4 million across 5 years, with a median of $55.8 million in 2023.
  • Biggest five-year swings in Revenue: skyrocketed 78.99% in 2021 and later dropped 3.19% in 2025.
  • Year by year, Revenue stood at $25.0 million in 2021, then surged by 53.11% to $38.3 million in 2022, then skyrocketed by 72.47% to $66.1 million in 2023, then soared by 30.54% to $86.3 million in 2024, then increased by 0.81% to $87.0 million in 2025.
  • Business Quant data shows Revenue for CSTL at $87.0 million in Q4 2025, $83.0 million in Q3 2025, and $86.2 million in Q2 2025.